Brief: Y-mAbs Announces Scheduling Of FDA Advisory Committee Meeting For Omburtamab

Y-mAbs Therapeutics

01/09/2022 21:50

Sept 1 (Reuters) - Y-mAbs Therapeutics Inc  YMAB.O :
    * Y-MABS ANNOUNCES SCHEDULING OF FDA ADVISORY COMMITTEE
MEETING
FOR OMBURTAMAB
    * Y-MABS THERAPEUTICS -  ONCOLOGIC DRUGS ADVISORY COMMITTEE
MEETING  SCHEDULED FOR OCT 28, 2022 TO REVIEW BIOLOGICAL LICENSE
APPLICATION FOR OMBLASTYS

Source text for Eikon:  ID:nGNX7RZt4l 
Further company coverage:  YMAB.O 

 ((Reuters.Briefs@thomsonreuters.com;))